CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Barclays Global Healthcare Conference Transcript

Mar 12, 2019 / 12:30PM GMT
Release Date Price: R$20.73
Steven J. James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Okay, great. I see the clock just started cranking here. We'll start our next session. I'm Steve Valiquette, the healthcare services analyst here at Barclays. This is the CVS session. This will be a fireside chat. To my right here is Eva Boratto, the company's new CFO. I also want to introduce Alan Lotvin. He's the EVP of Transformation at CVS, which I think will be a pretty critical role. I think Alan wanted to spend maybe a minute kind of giving more kind of his background, et cetera, and kind of what some of his initiatives are.

So I'll turn it over to Alan first, then we'll blaze through a long list of questions.

Alan M. Lotvin
CVS Health Corporation - EVP of Transformation

Great. Thanks, Steve. I'll take just 1 minute. So just my background. I'm an interventional cardiologist. I've been in health services for about 22 years, and most of the last 17 of those have been in specialty pharmacy. I took on this role as a Chief Transformation Officer about 9 months ago,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot